Skip to main content
SpringerLink
Log in

Oral Signs of Tropical, Fungal, and Parasitic Diseases

  • Chapter
  • First Online:
Book cover Oral Signs of Systemic Disease

  • 1298 Accesses

Abstract

More than 50% of the world population live in the tropics mostly in developing countries, with great poverty and poor essential goods, services, and access. These conditions and environmental factors make the population high risk for a group of fungal, bacterial, and parasitic diseases, many of which affect the oral mucosa.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Arenas R, Estrada R. Tropical dermatology, Vademècum. Georgetown: Landes Biosciences; 2001. ISBN1-57059-493-7.

    Google Scholar 

  2. Bonifaz A. Micología Médica Básica cuarta Edición. New York: McGraw Hill; 2012.

    Google Scholar 

  3. Martins N, Ferreira IC, Barros L, Silva S, Henriques M. Candidiasis: predisposing factors, preventions, diagnosis and alternative treatment. Mycopathologia. 2014;177:223–40.

    CAS  PubMed  Google Scholar 

  4. Bork K, Hoede N, Korting G, Burgdorf W, Young S. Diseases of the oral mucosa and the lips. 2nd ed. Philadelphia: WB Saunders; 1996.

    Google Scholar 

  5. Sakaguchi H. Treatment and prevention of oral candidiasis in elderly patients. Med Mycol J. 2017;58:J43–9.

    PubMed  Google Scholar 

  6. Hani U, Shivakumar HG, Vaghela R, Osmani RAM, Shrivastava A. Candidiasis: a fungal infection- current challenges and progress in prevention and treatment. Infect Disord – Drug Targets. 2015;15:42–52.

    CAS  PubMed  Google Scholar 

  7. Moghimi M, Salentijn E, Debets-Ossenkop Y, Karagozoglu KH, Forounzanfar T. Treatment of cervicofacial actinomycosis: a report of 19 cases and review of literature. Med Oral Patol Oral Cir Bucal. 2013;18:e627–32.

    PubMed  PubMed Central  Google Scholar 

  8. Kolm I, Aceto L, Hombach M, Kamarshev J, Hafner J, Urosevic-Maiwald M. Cervicofacial actinomycosis: a long forgotten infectious complication of immunosuppression – report of a case and review of the literature. Dermatol Online J. 2014;20:22640.

    PubMed  Google Scholar 

  9. Valour F, Sénéchal A, Dupieux C, Karsenty J, Lustig S, Breton P, et al. Actinomycosis: etiology, clinical features, diagnosis, treatment, and management. Infect Drug Resist. 2014;7:183–97.

    PubMed  PubMed Central  Google Scholar 

  10. Fadda GL, Gisolo M, Crosetti E, Fulcheri A, Succo G. Intracranial complication of rhinosinusitis from actinomycosis of the paranasal sinuses: a rare case of abducens nerve palsy. Case Rep Otolaryngol. 2014;2014:601671.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Cohen PR, Tschen JA. Tonsillar actinomycosis mimicking a tonsillolith: colonization of the palantine tonsil presenting as a foul-smelling, removable, unilateral, giant tonsillar concretion. Int J Dermatol. 2010;49:1165–8.

    PubMed  Google Scholar 

  12. Eidbo J, Sanchez RL, Tschen JA, Ellner KM. Cutaneous manifestations of histoplasmosis in the acquired immune deficiency syndrome. Am J Surg Pathol. 1993;17:110–6.

    CAS  PubMed  Google Scholar 

  13. Marques SA, Silvares MR, Camargo RM, Marques ME. Cutaneous histoplasmosis disclosing an HIV-infection. An Bras Dermatol. 2013;88:420–3.

    PubMed  PubMed Central  Google Scholar 

  14. Corti M, Villafañe MF, Palmieri O, Negroni R. Rupioid histoplasmosis: first case reported in an AIDS patient in Argentina. Rev Inst Med Trop Sao Paulo. 2010;52:279–80.

    PubMed  Google Scholar 

  15. Ollague Sierra JEI, Ollague Torres JM. New clinical and histological pattern of acute disseminated histoplasmosis in human immunodeficiency virus positive patients with acquired immunodeficiency syndrome. Am J Dermatophatol. 2013;35:203–12.

    Google Scholar 

  16. Ge L, Zhou C, Song Z, Zhang Y, Wang L, Zhong B, Hao F. Primary localized histoplasmosis with lesions restricted to the mouth in a Chinese HIV negative patient. Int J Infect Dis. 2010;14(Suppl 3):e325–8.

    PubMed  Google Scholar 

  17. Iqbal FL, Schifter M, Coleman HG. Oral presentation of histoplasmosis in an immunocompetent patient: a diagnostic challenge. Aust Dent J. 2014;59:386–8.

    CAS  PubMed  Google Scholar 

  18. Wheat J, Freifeld AG, Kleiman MB, Baddley JW, McKinsey DS, Loyd JE, Kauffman CA, Infectious Diseases Society of America. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007;45:807–25.

    PubMed  Google Scholar 

  19. Restrepo A, Tobon A, Clark B, Graham DR, Corcoran G, Bradsher RW, et al. Salvage treatment of histoplasmosis with posaconazole. J Inf Secur. 2007;54:319–27.

    Google Scholar 

  20. Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards J Jr, Ibrahim AS. Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis. 2009;48:1743–51.

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Marques SA. Fungal infections of the mucous membrane. Dermatol Ther. 2010;23:244–51.

    Google Scholar 

  22. Bonifaz A, Macias B, Paredes-Farreira F, Arias P, Ponce RM, Araiza J. Palatal zygomycosis: experience of 21 cases. Oral Dis. 2008;14:569–74.

    CAS  PubMed  Google Scholar 

  23. Kontoyiannis DP, Wessel VC, Bodey GP, Rolston KV. Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis. 2000;30:851–6.

    CAS  PubMed  Google Scholar 

  24. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2002;34:909–17.

    PubMed  Google Scholar 

  25. Bonifaz A, Vázquez-González D, Tirado-Sánchez A, Ponce-Olivera RM. Cutaneous zygomycosis. Clin Dermatol. 2012;30:413–9.

    PubMed  Google Scholar 

  26. Bonifaz A, Tirado-Sánchez A, Calderón L, Romero-Cabello R, Kassack J, Ponce RM, et al. Mucormycosis in children: a study of 22 cases in a Mexican hospital. Mycoses. 2014;57(Suppl 3):79–84.

    PubMed  Google Scholar 

  27. Ameen M, Arenas R, Martinez-Luna E, Reyes M, Zacarias R. The emergence of mucormycosis as an important opportunistic fungal infection: five cases presenting to a tertiary referral center for mycology. Int J Dermatol. 2007;46:380–4.

    PubMed  Google Scholar 

  28. Reed G, Ibrahim A, Edwards J Jr. Deferasirox, an iron-chelating agent, as salvage therapy for rhinocerebral mucormycosis. Antimicrob Agents Chemother. 2006;50:3968–9.

    PubMed  PubMed Central  Google Scholar 

  29. Bagagli E, Theodoro RC, Bosco SM, McEwen JG. Paracoccidioidesbrasiliensis: phylogenetic and ecological aspects. Mycopathologia. 2008;165:197–207.

    PubMed  Google Scholar 

  30. Matute DR, McEwen JG, Puccia R, Montes BA, San-Blas G, Bagagli E, et al. Cryptic speciation and recombination in the fungus Paracoccidioidesbrasiliensis as revealed by gene genealogies. Mol Biol Evol. 2006;23:65–73.

    CAS  PubMed  Google Scholar 

  31. Matute DR, Sepulveda VE, Quesada LM, Goldman GH, Taylor JW, Restrepo A, et al. Microsatellite analysis of three phylogenetic species of Paracoccidioidesbrasiliensis. J Clin Microbiol. 2006;44:2153–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Teixeira MM, Theodoro RC, de Carvalho MJ, Fernandes L, Paes HC, Hahn RC. Phylogenetic analysis reveals a high level of speciation in the Paracoccidioides genus. Mol Phylogenet Evol. 2009;52:273–83.

    PubMed  Google Scholar 

  33. Theodoro RC, Teixeira Mde M, Felipe MS, Paduan Kdos S, Ribolla PM, San-Blas G, et al. Genus Paracoccidioides: species recognition and biogeographic aspects. PLoSOne. 2012;7:e37694.

    CAS  Google Scholar 

  34. Turissini DA, Gomez OM, Teixeira MM, McEwen JG, Matute DR. Species boundaries in the human pathogen Paracoccidioides. Fungal Genet Biol. 2017;106:9–25.

    PubMed  Google Scholar 

  35. Bellissimo-Rodrigues F, Machado AA, Martinez R. Paracoccidioidomycosis epidemiological features of a 1,000-cases series from a hyperendemic area on the Southeast of Brazil. Am J Trop Med Hyg. 2011;85:546–50.

    PubMed  PubMed Central  Google Scholar 

  36. Marques SA. Paracoccidioidomycosis: epidemiological, clinical, diagnostic and treatment up-dating. An Bras Dermatol. 2013;88:700–11.

    PubMed  PubMed Central  Google Scholar 

  37. Franco M, Montenegro MR, Mendes RP, Marques SA, Dillon N, Mota NGS. Paracoccidioidomycosis: a recently proposed classification of its clinical forms. Rev Soc Bras Med Trop. 1987;20:129–32.

    CAS  PubMed  Google Scholar 

  38. Marques SA, Cortez DB, Lastória JC, Camargo RMP, Marques MEA. Paracoccidioidomycosis: frequency, morphology and pathogenesis of tegumentary lesions. An Bras Dermatol. 2007;82:411–7.

    Google Scholar 

  39. Queiroz-Telles F, Goldani LZ, Schlamm HT, Goodrich JM, Espinel-Ingroff A, Shikanai-Yasuda MA. An open-label comparative pilot study of oral voriconazole and itraconazole for long-term treatment of paracoccidioidomycosis. Clin Infect Dis. 2007;45:1462–9.

    CAS  PubMed  Google Scholar 

  40. Peçanha PM, Souza S, Falqueto A, Grão-Veloso TR, Lírio LV, Ferreira CUG Jr, et al. Amphotericin B lipid complex in the treatment of severe paracoccidioidomycosis: a case series. Int J Antimicrob Agents. 2016;48:428–30.

    PubMed  Google Scholar 

  41. Shikanai-Yasuda MA, TellesFilho FQ, Mendes RP, Colombo AL, Moretti ML. Grupo de Consultores do Consenso em Paracoccidiodomicose. Consenso em paracoccidioidomicose. Rev Soc Bras Med Trop. 2006;39:297–310.

    PubMed  Google Scholar 

  42. Saccente M, Woods GL. Clinical and laboratory update on blastomycosis. Clin Microbiol Rev. 2010;23:367–81.

    PubMed  PubMed Central  Google Scholar 

  43. Rucci J, Eisinger G, Miranda-Gomez G, Nguyen J. Blastomycosis of the head and neck. Am J Otolaryngol. 2014;35:390–5.

    CAS  PubMed  Google Scholar 

  44. Kruse AL, Zwahlen RA, Bredell MG, Gengler C, Dannemann C, Grätz KW. Primary blastomycosis of oral cavity. J Craniofac Surg. 2010;21:121–3.

    PubMed  Google Scholar 

  45. Fanucci E, Nezzo M, Neroni L, Montesani L Jr, Ottria L, Gargari M. Diagnosis and treatment of paranasal sinus fungus ball of odontogenic origin: case report. Oral Implantol (Rome). 2014;6(3):63–6.

    Google Scholar 

  46. Grosjean P, Weber R. Fungus balls of the paranasal sinuses: a review. Eur Arch Otorhinolaryngol. 2007;264:461–70.

    PubMed  Google Scholar 

  47. Ganesh P, Nagarjuna M, Shetty S, Kumar P, Bhat V, Salins PC. Invasive aspergillosis presenting as swelling of the buccal mucosa in an immunocompetent individual. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119:e60–4.

    PubMed  Google Scholar 

  48. MacDougall L, Fyfe M, Romney M, Starr M, Galanis E. Risk factors for Cryptococcus gattii infection, British Columbia. Canada Emerg Infect Dis. 2011;17:193–9.

    PubMed  Google Scholar 

  49. Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America. Clin Infect Dis. 2010;50:291–322.

    PubMed  PubMed Central  Google Scholar 

  50. Viviani MA. Cryptococcal meningitis: diagnosis and treatment. Int J Antimicrob Agents. 1996;6:169–73.

    CAS  PubMed  Google Scholar 

  51. Thomas I, Schwartz RA. Cutaneous manifestations of systemic cryptococcosis in immunosuppressed patients. J Med. 2001;32:259–66.

    CAS  PubMed  Google Scholar 

  52. Negroni R. Cryptococcosis. Clin Dermatol. 2012;30:599–609.

    PubMed  Google Scholar 

  53. Marques SA, Bastazini I Jr, Martins AL, Barreto JÁ, Barbieri D’Elia MP, Lastória JC, et al. Primary cutaneous cryptococcosis in Brazil: report of 11 cases in immuno competent and immunosuppressed patients. Int J Dermatol. 2012;51:780–4.

    PubMed  Google Scholar 

  54. Nascimento E, Bonifácio da Silva ME, Martinez R, Von ZeskaKress MR. Primary cutaneous cryptococcosis in an immunocompetent patient due to Cryptococcus gattii molecular type VGI in Brazil: a case report and review of the literature. Mycoses. 2014;57(7):442–7.

    PubMed  Google Scholar 

  55. Patel P, Ramanathan J, Kayser M, Baran JJR. Primary cutaneous cryptococcosis of the nose in an immunocompetent woman. J Am Acad Dermatol. 2000;43:344–5.

    CAS  PubMed  Google Scholar 

  56. Pau M, Lallai C, Aste N, Aste N, Atzori L. Primary cutaneous cryptococcosis in an immunocompetent host. Mycoses. 2010;53:256–8.

    PubMed  Google Scholar 

  57. Iatta R, Napoli C, Borghi, Montagna MT. Rare mycosis of oral cavity: a literature epidemiological review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108:647–55.

    PubMed  Google Scholar 

  58. Faria PF, Vargas PA, Saldiva PH, Böhm GM, Mauad T, de Almeida OP. Tongue disease in advanced AIDS. Oral Dis. 2005;11:72–80.

    PubMed  Google Scholar 

  59. Liew C, Barreto L, Mills C. Interesting case: an unusual case of oral ulceration. Br J Oral Maxillofac Surg. 2006;44:350.

    CAS  PubMed  Google Scholar 

  60. Mohamad I, Abdullah B, Salim R, Rajet KA, Naik VR. Cryptococcosis: a rare fungal infection of the tongue. Southeast Asian J Trop Med Public Health. 2010;41:1188–91.

    PubMed  Google Scholar 

  61. Patel S, Navas M, Batt C, Jump RLP. Oral cryptococcosis in a patient with chronic lymphocytic leukemia. Int J Infect Dis. 2016;50:18–20.

    PubMed  PubMed Central  Google Scholar 

  62. Kantarcioglu AS, Gulenc M, Yücel A, Uzun N, Taskin T, Sakiz D, Altas K. Cryptococcal parotid involvement: an uncommon localization of Cryptococcus neoformans. Med Mycol. 2006;44:279–83.

    PubMed  Google Scholar 

  63. Wong DJY, Stanley P, Paddle P. Laryngeal cryptococcosis associated with inhaled corticosteroid use: case report and review of the literature. Front Surg. 2017;4:e63.

    Google Scholar 

  64. Kwon-Chung KJ, Bennett JE. Cryptococcosis. In: Kwon-Chung KJ, Bennett JE, editors. Medical mycology. Philadelphia: Lea & Febiger; 1992. p. 397–446.

    Google Scholar 

  65. Benedict K, Park BJ, Thompson GR 3rd. Coccidioidomycosis: epidemiology. Clin Epidemiol. 2013;5:185–97.

    PubMed  PubMed Central  Google Scholar 

  66. Welsh O, Vera-Cabreira L, Rendon A, Gonzalez G, Bonifaz A. Coccidioidomycosis. Clin Dermatol. 2012;30:573–91.

    PubMed  Google Scholar 

  67. Kwon-Chung KJ, Bennett JE. Coccidioidomycosis. In: Kwon-Chung KJ, Bennett JE, editors. Medical mycology. Philadelphia: Lea & Febiger; 1992. p. 357–97.

    Google Scholar 

  68. Blair JE, Chang YH, Cheng MR, Vaszar LT, Vikram HR, Orenstein R, et al. Characteristics of patients with mild to moderate primary pulmonary coccidioidomycosis. Emerg Infect Dis. 2014;20:983–90.

    PubMed  PubMed Central  Google Scholar 

  69. Rosenstein NE, Emery KW, Werner SB, Kao A, Johnson R, Rogers D, et al. Risk factor for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995–1996. Clin Infect Dis. 2001;32:708–16.

    CAS  PubMed  Google Scholar 

  70. Odio CD, Marciano BE, Galgiani JN, Holland SM. Risk factor for disseminated coccidioidomycosis, United States. Emerg Infect Dis. 2017;23:308–11.

    CAS  PubMed Central  Google Scholar 

  71. Galgiani JN, Ampel NM, Blair JE, Catanzaro A, Johnson RH, Stevens DA, Williams PL, Infectious Diseases Society of America. Coccidioidomycosis. Clin Infect Dis. 2005;41(9):1217–23.

    PubMed  Google Scholar 

  72. Center of Disease Control and Prevention. Increase in reported coccidioidomycosis: United States 1998–2011. MMWR Morb Mortal Wkly Rep. 2013;62:217–21.

    Google Scholar 

  73. Rodriguez RA, Konia T. Coccidioidomycosis of the tongue. Arch Patol Lab Med. 2005;129:e4–6.

    Google Scholar 

  74. Stich A, Müller A, Tintelnot K. Coccidioidomycosis with manifestation on the tongue. Pathologe. 2013;34:548–51.

    CAS  PubMed  Google Scholar 

  75. Mendez LA, Florez SA, Martinez R, Almeida OP. Ulcerated lesion of the tongue as manifestation of systemic coccidioidomycosis. Case Rep Med. 2017; https://doi.org/10.1155/2017/1489501.

  76. Galgiani JN, Ampel NM, Blair JE. 2016 Infectious Diseases Society of America (IDSA) clinical practice guidelines for the treatment of Coccidioidomycosis. Clin Infect Dis. 2016;61:717–22.

    Google Scholar 

  77. Ameen M. Cutaneous leishmaniasis: advances in disease pathogenesis, diagnostics and therapeutics. Clin Exp Dernatol. 2010;35:699–705.

    CAS  Google Scholar 

  78. Ramos-e-Silva M. Diseases of the oral cavity caused by Protozoa. In: Lotti TM, Parish LC, Rogers IIIRS, editors. Oral diseases. Textbook and Atlas. Berlin: Springer-Verlag; 1999. p. 122–5.

    Google Scholar 

  79. Mignogna MD, Celentano A, Leuci S, Cascone M, Adamo D, Ruoppo E, Favia G. Mucosal leishmaniasis with primary oral involvement: a case series and a review of the literature. Oral Dis. 2015;21(1):e70–8.

    CAS  PubMed  Google Scholar 

  80. García de Marcos JA, Dean Ferrer A, Alamillos Granados F, Ruiz Masera JJ, Cortés Rodríguez B, Vidal Jiménez A, et al. Localized Leishmaniasis of the oral mucosa. A report of three cases. Med Oral Patol Oral Cir Bucal. 2007;12(4):E281–6.

    PubMed  Google Scholar 

  81. Da Costa DC, Palmeiro MR, Moreira JS, Martins AC, da Silva AF, Madeira Mde F, et al. Oral manifestations in the American tegumentary leishmaniasis. PLoS One. 2014;9:e109790.

    PubMed  PubMed Central  Google Scholar 

  82. Milián MA, Bagán JV, Jiménez Y, Pérez A, Scully C. Oral leishmaniasis in a HIV-positive patient. Report of a case involving the palate. Report of a case involving the palate. Oral Dis. 2002;8:59–61.

    PubMed  Google Scholar 

  83. Passi D, Sharma S, Dutta, S, Gupta C. Localized leishmaniasis of oral mucosa: Report of an unusual clinicopathological entity. Hindawi Publishing Corporation. Case Reports in Dentistry. 2014;753149. https://doi.org/10.1155/2014/753149.

  84. Kassam K, Davidson R, Tadrous PJ, Kumar M. Lingual Leishmaniasis presenting to maxillofacial surgery in UK with successful treatment with miltefosine. Case Rep Med. 2013;2013:975131.

    CAS  PubMed  PubMed Central  Google Scholar 

  85. Daneshbod Y, Oryan A, Davarmanesh M, Shirian S, Negahban S, Aledavood A, et al. Clinical, histopathologic, and cytologic diagnosis of mucosal leishmaniasis and literature review. Arch Pathol Lab Med. 2011;135:478–82.

    PubMed  Google Scholar 

  86. Almeida TF, da Silveira EM, Dos Santos CR, León JE, Mesquita AT. Exclusive primary lesion of oral leishmaniasis with Immunohistochemical diagnosis. Head Neck Pathol. 2016;10:533–7.

    PubMed  PubMed Central  Google Scholar 

  87. Crovetto-Martínez R, Aguirre-Urizar JM, Orte-Aldea C, Araluce-Iturbe I, Whyte-Orozco J, Crovetto-De la Torre MA. Mucocutaneous leishmaniasis must be included in the differential diagnosis of midline destructive disease: two case reports. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119(1):e20–6.

    PubMed  Google Scholar 

  88. Minodier P, Parola P. Cutaneous leishmaniasis treatment. Travel Med Infect Dis. 2007;5:150–8.

    PubMed  Google Scholar 

  89. Amato VS, Tuon FF, Siqueira AM, Nicodemo AC, Neto VA. Treatment of mucosal leishmaniasis in Latin America: systematic review. Am J Trop Med Hyg. 2007;77:266–74.

    CAS  PubMed  Google Scholar 

  90. Zerpa O, Blanco B, Kannee C, Ulrich M, Sindermann H, Engel J, Convit J. Treatment of diffuse cutaneous leishmaniasis with miltefosine: a case report. Int J Dermatol. 2006;45:751–3.

    PubMed  Google Scholar 

  91. Vélez I, López L, Sánchez X, Mestra L, Rojas C, Rodriguez E. Efficacy of miltefosine for the treatment of American cutaneous leishmaniasis. Am J Trop Med Hyg. 2010;83:351–6.

    PubMed  PubMed Central  Google Scholar 

  92. Zerpa O, Ulrich M, Blanco B, Polegre M, Avila A, Matos N, et al. Diffuse cutaneous leishmaniasis responds to miltefosine but then relapses. Br J Dermatol. 2007;156:1328–35.

    CAS  PubMed  Google Scholar 

  93. Convit J, Ulrich M, Zerpa O, Borges R, Aranzazu N, Valera M, et al. Immunotherapy of american cutaneous leishmaniasis in Venezuela during the period 1990–99. Trans R Soc Trop Med Hyg. 2003;97(4):469–72.

    CAS  PubMed  Google Scholar 

  94. Convit J, Ulrich M, Polegre MA, Avila A, Rodríguez N, Mazzedo MI, et al. Therapy of Venezuelan patients with severe mucocutaneous or early lesions of diffuse cutaneous leishmaniasis with a vaccine containing pasteurized Leishmania promastigotes and bacillus Calmette-Guerin: preliminary report. Mem Inst Oswaldo Cruz. 2004;99:57–62.

    PubMed  Google Scholar 

  95. Ameen M. The potential of daylight-activated photodynamic therapy for treating localized forms of cutaneous leishmaniasis in resource-limited settings. Br J Dermatol. 2015;172:1192–3.

    CAS  PubMed  Google Scholar 

  96. Marks M, Solomon AW, Mabey DC. Endemic Treponemal disease. Trans R Soc Trop Med Hyg. 2014;108:601–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  97. Koff AB, Rosen T. Non venereal treponematoses: yaws, endemic syphilis, and pinta. J Am Acad Dermatol. 1993;29:519–35.

    CAS  PubMed  Google Scholar 

  98. Antal GM, Lukehart SA, Meheus AZ. The endemic treponematoses. Microbes Infect. 2002;4:83–94.

    PubMed  Google Scholar 

  99. Giacani L, Lukehart SA. The endemic treponematoses. Clin Microbiol Rev. 2014;27:89–115.

    PubMed  PubMed Central  Google Scholar 

  100. Radolf JD. Treponema. In: Baron S, editor. Medical microbiology. 4th ed. Galveston: University of Texas Medical Branch at Galveston; 1996. Chapter 36.

    Google Scholar 

  101. Marks M, Mitjà O, Solomon AW, Asiedu KB, Mabey DC. Yaws. Br Med Bull. 2015;113:91–100.

    PubMed  Google Scholar 

  102. Marks M, Lebari D, Solomon AW, Higgins SP. Yaws. Int J STD AIDS. 2015;26:696–703.

    CAS  PubMed  Google Scholar 

  103. Mitjà O, Asiedu K, Mabey D. Yaws. Lancet. 2013;381:763–73.

    PubMed  Google Scholar 

  104. Kazadi WM, Asiedu KB, Agana N, Mitjà O. Epidemiology of yaws: an update. Clin Epidemiol. 2014;6:119–28.

    PubMed  PubMed Central  Google Scholar 

  105. Mitjà O, Hays R, Ipai A, Penias M, Paru R, Fagaho D, et al. Single-dose azithromycin versus benzathinebenzylpenicillin for treatment of yaws in children in Papua New Guinea: an open-label, non-inferiority, randomised trial. Lancet. 2012;379:342–7.

    PubMed  Google Scholar 

  106. Kwakye-Maclean C, Agana N, Gyapong J, Nortey P, Adu-Sarkodie Y, Aryee E, et al. A single dose oral azithromycin versus intramuscular benzathine penicillin for the treatment of yaws-a randomized non inferiority trial in Ghana. PLoS Negl Trop Dis. 2017;11(1):e0005154.

    PubMed  PubMed Central  Google Scholar 

  107. Fegan D, Glennon MJ, Kool J, Taleo F. Tropical leg ulcers in children: more than yaws. Trop Dr. 2016;46:90–3.

    Google Scholar 

  108. Rivera-Olivero IA, Guevara A, Escalona A, Oliver M, Pérez-Alfonzo R, Piquero J, et al. Soft-tissue infections due to non-tuberculous mycobacteria following mesotherapy. What is the price of beauty. Enferm Infecc Microbiol Clin. 2006;24:302–6.

    PubMed  Google Scholar 

  109. Torres-Coy JA, Rodríguez-Castillo BA, Pérez-Alfonzo R, DE Waard JH. Source investigation of two outbreaks of skin and soft tissue infection by Mycobacterium abscessus subsp. abscessus in Venezuela. Epidemiol Infect. 2016;144:1117–20.

    CAS  PubMed  Google Scholar 

  110. Peralta G, Tobin-D’Angelo M, Parham A, Edison L, Lorentzson L, Smith C, et al. Notes from the field: Mycobacterium abscessus infections among patients of a pediatric dentistry practice – Georgia, 2015. MMWR Morb Mortal Wkly Rep. 2016;65:355–6.

    PubMed  Google Scholar 

  111. Lange CG, Woolley IJ, Brodt RH. Disseminated mycobacterium avium-intracellulare complex (MAC) infection in the era of effective antiretroviral therapy: is prophylaxis still indicated? Drugs. 2004;64:679–92.

    CAS  PubMed  Google Scholar 

  112. Safraneck TJ, Jarvis WR, Carson LA, Cusick LB, Bland LA, Swenson JM, Silcox VA. Myobacterirum chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution. N Engl J Med. 1987;317:197–201.

    Google Scholar 

  113. Murillo J, Torres J, Bofill L, Ríos-Fabra A, Irausquin E, Istúriz R, et al. Skin and wound infection by rapidly growing mycobacteria: an unexpected complication of liposuction and liposculpture. The Venezuelan Collaborative Infectious and Tropical Diseases Study Group. Arch Dermatol. 2000;136:1347–52.

    CAS  PubMed  Google Scholar 

  114. Robinson P, Farthing P, Scott GM, Bennett JH. Oral Mycobacterium avium complex infection in a patient with HIV-related disease. A case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;81:177–9.

    CAS  PubMed  Google Scholar 

  115. Alagarswamy RK, Halfpenny W, Thiruchelvam JK, Mohamid W. Rare presentation of Mycobacterium avium-intracellulare infection. Br J Oral Maxillofac Surg. 2007;45:670–2.

    PubMed  Google Scholar 

  116. Cox HJ, Brightwell AP, Riordan T. Non-tuberculous mycobacterial infections presenting as salivary gland masses in children: investigation and conservative management. J Laryngol Otol. 1995;109:525–30.

    CAS  PubMed  Google Scholar 

  117. Berkovic J, Vanchiere JA, Gungor A. Non tuberculous mycobacterial lesion of the parotid gland and facial skin in a 4 year old girl: a proposed treatment strategy. Am J Otolaryngol. 2016;37:89–94.

    PubMed  Google Scholar 

  118. Bonali M, Mattioli F, Alicandri-Ciufelli M, Presutti L. Atypical mycobacteriosis involving parotid and para-retropharyngeal spaces. Eur Arch Otorhinolaryngol. 2016;273:4031–3.

    PubMed  Google Scholar 

  119. Yamanaka T, Okamoto H, Hosoi H. Non-tuberculous mycobacterial infection of the parotid gland in an immunocompetent elderly patient. BMJ Case Rep. 2013;16:2013.

    Google Scholar 

  120. Motswaledi MH, Khammissa RA, Jadwat Y, Lemmer J, Feller L. Oral sarcoidosis: a case report and review of the literature. Aust Dent J. 2014;59:389–94.

    CAS  PubMed  Google Scholar 

  121. Sharma P, Saxena S, Aggarwal P, Reddy V. Tuberculosis of odontogenic cyst. Indian J Tuberc. 2013;60:50–4.

    PubMed  Google Scholar 

Download references

Acknowledgment

The authors would like to acknowledge the valuable suggestions made by Lic. María Eugenia Gallinoto (Instituto de Biomedicina “Dr. Jacinto Convit,” Universidad Central de Venezuela) and Dr. Jacobus H. de Waard (Microbiologist Tuberculosis Department, Instituto de Biomedicina “Dr. Jacinto Convit,” Universidad Central de Venezuela).

Author information

Authors and Affiliations

  1. Dermatologic Program, “Jacinto Convit” Institute of Biomedicine, Central University of Venezuela, Caracas, Venezuela

    Ricardo Pérez-Alfonzo

  2. Department of Dermatology and Radiotherapy, Botucatu School of Medicine – São Paulo State University (UNESP), Botucatu, Brazil

    Silvio Alencar-Marques

  3. University Hospital Caracas, Central University of Venezuela, Caracas, Venezuela

    Elda Giansante

  4. Pierre Fauchard Faculty of Dentistry, Autonomous University of Paraguay, Asunción, Paraguay

    Antonio Guzmán-Fawcett

Authors
  1. Ricardo Pérez-Alfonzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Silvio Alencar-Marques
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elda Giansante
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Antonio Guzmán-Fawcett
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Dermatology, University of California, Davis, Sacramento, CA, USA

    Nasim Fazel

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Pérez-Alfonzo, R., Alencar-Marques, S., Giansante, E., Guzmán-Fawcett, A. (2019). Oral Signs of Tropical, Fungal, and Parasitic Diseases. In: Fazel, N. (eds) Oral Signs of Systemic Disease. Springer, Cham. https://doi.org/10.1007/978-3-030-10863-2_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-10863-2_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-10861-8

  • Online ISBN: 978-3-030-10863-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation